Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size ($ in 1000's) |
---|---|---|---|
INSMED INC | 5,350,000 | -650,000 | $165,796 |
INSM | 5,350,000 | -650,000 | $165,796 |
SPRINGWORKS THERAPEUTICS INC | 4,063,676 | +517,241 | $148,324 |
SWTX | 4,063,676 | +517,241 | $148,324 |
INTRA CELLULAR THERAPIES INC | 2,000,000 | -600,000 | $143,240 |
ITCI | 2,000,000 | -600,000 | $143,240 |
CYTOKINETICS INC | $136,610 | ||
Call | 1,347,300 | +1,347,300 | $112,486 |
CYTK | 288,949 | +288,949 | $24,124 |
GUARDANT HEALTH INC | 5,000,000 | +950,000 | $135,250 |
GH | 5,000,000 | +950,000 | $135,250 |
ARGENX SE | 300,000 | +300,000 | $114,129 |
ARGX | 300,000 | +300,000 | $114,129 |
ALKERMES PLC | 4,000,000 | +200,000 | $110,960 |
ALKS | 4,000,000 | +200,000 | $110,960 |
PLIANT THERAPEUTICS INC | 5,750,000 | +250,000 | $104,132 |
PLRX | 5,750,000 | +250,000 | $104,132 |
DYNAVAX TECHNOLOGIES CORP | 7,093,214 | +336,258 | $99,163 |
DVAX | 7,093,214 | +336,258 | $99,163 |
AXSOME THERAPEUTICS INC | 1,000,000 | -140,745 | $79,590 |
AXSM | 1,000,000 | -140,745 | $79,590 |
VIRIDIAN THERAPEUTICS INC | 3,631,728 | +668,461 | $79,099 |
VRDN | 3,631,728 | +668,461 | $79,099 |
AUTOLUS THERAPEUTICS PLC | 11,869,297 | -3,130,703 | $76,438 |
AUTL | 11,869,297 | -3,130,703 | $76,438 |
PACIFIC BIOSCIENCES CALIF IN | 7,000,000 | +1,000,000 | $68,670 |
PACB | 7,000,000 | +1,000,000 | $68,670 |
INTELLIA THERAPEUTICS INC | 2,250,000 | +250,000 | $68,602 |
NTLA | 2,250,000 | +250,000 | $68,602 |
TRAVERE THERAPEUTICS INC | 7,370,000 | UNCH | $66,256 |
TVTX | 7,370,000 | UNCH | $66,256 |
APOGEE THERAPEUTICS INC | 2,323,456 | -90,917 | $64,917 |
APGE | 2,323,456 | -90,917 | $64,917 |
VERONA PHARMA PLC | 3,187,415 | UNCH | $63,366 |
VRNA | 3,187,415 | UNCH | $63,366 |
IONIS PHARMACEUTICALS INC | 1,249,068 | -1,585,001 | $63,190 |
IONS | 1,249,068 | -1,585,001 | $63,190 |
BICYCLE THERAPEUTICS PLC | 3,490,506 | UNCH | $63,108 |
BCYC | 3,490,506 | UNCH | $63,108 |
GERON CORP | 29,583,449 | +3,883,449 | $62,421 |
GERN | 29,583,449 | +3,883,449 | $62,421 |
EDITAS MEDICINE INC | 5,473,086 | -1,628,849 | $55,442 |
EDIT | 5,473,086 | -1,628,849 | $55,442 |
AMBRX BIOPHARMA INC | 3,710,412 | +3,710,412 | $52,836 |
AMAM | 3,710,412 | +3,710,412 | $52,836 |
SAREPTA THERAPEUTICS INC | 500,000 | +500,000 | $48,215 |
SRPT | 500,000 | +500,000 | $48,215 |
TOURMALINE BIO INC | 1,815,854 | +1,815,854 | $47,539 |
TRML | 1,815,854 | +1,815,854 | $47,539 |
HILLEVAX INC | 2,900,000 | UNCH | $46,545 |
HLVX | 2,900,000 | UNCH | $46,545 |
4D MOLECULAR THERAPEUTICS IN | 2,284,372 | -493,735 | $46,281 |
FDMT | 2,284,372 | -493,735 | $46,281 |
ABIVAX SA | 4,297,438 | +4,297,438 | $45,983 |
ABVX | 4,297,438 | +4,297,438 | $45,983 |
RAPT THERAPEUTICS INC | 1,793,966 | +293,966 | $44,580 |
RAPT | 1,793,966 | +293,966 | $44,580 |
ANAPTYSBIO INC | 2,036,990 | +691,177 | $43,632 |
ANAB | 2,036,990 | +691,177 | $43,632 |
IMMUNOVANT INC | 1,000,000 | -1,797,955 | $42,130 |
IMVT | 1,000,000 | -1,797,955 | $42,130 |
OCULAR THERAPEUTIX INC | 9,230,769 | +9,230,769 | $41,169 |
OCUL | 9,230,769 | +9,230,769 | $41,169 |
ARCELLX INC | 725,145 | +725,145 | $40,246 |
ACLX | 725,145 | +725,145 | $40,246 |
TERNS PHARMACEUTICALS INC | 6,100,000 | +100,000 | $39,589 |
TERN | 6,100,000 | +100,000 | $39,589 |
SILENCE THERAPEUTICS PLC | 1,951,580 | UNCH | $33,899 |
SLN | 1,951,580 | UNCH | $33,899 |
ORCHARD THERAPEUTICS PLC | 2,041,670 | UNCH | $33,585 |
ORTX | 2,041,670 | UNCH | $33,585 |
NUVALENT INC | 450,000 | +450,000 | $33,116 |
NUVL | 450,000 | +450,000 | $33,116 |
ANI PHARMACEUTICALS INC | 600,000 | +200,000 | $33,084 |
ANIP | 600,000 | +200,000 | $33,084 |
NURIX THERAPEUTICS INC | 2,997,830 | UNCH | $30,938 |
NRIX | 2,997,830 | UNCH | $30,938 |
EDGEWISE THERAPEUTICS INC | 2,537,176 | -212,824 | $27,757 |
EWTX | 2,537,176 | -212,824 | $27,757 |
OLEMA PHARMACEUTICALS INC | 1,930,894 | UNCH | $27,090 |
OLMA | 1,930,894 | UNCH | $27,090 |
DYNE THERAPEUTICS INC | 2,000,000 | -403,672 | $26,600 |
DYN | 2,000,000 | -403,672 | $26,600 |
AGENUS INC | 31,697,539 | UNCH | $26,242 |
AGEN | 31,697,539 | UNCH | $26,242 |
AGIOS PHARMACEUTICALS INC | 1,062,881 | +640,634 | $23,670 |
AGIO | 1,062,881 | +640,634 | $23,670 |
SPYRE THERAPEUTICS INC | 1,952,760 | +1,952,760 | $23,453 |
AGLE | 1,952,760 | +1,952,760 | $23,453 |
REPARE THERAPEUTICS INC | 2,992,731 | -75,000 | $21,847 |
RPTX | 2,992,731 | -75,000 | $21,847 |
SCHOLAR ROCK HLDG CORP | 1,011,829 | +657,974 | $19,022 |
SRRK | 1,011,829 | +657,974 | $19,022 |
STRUCTURE THERAPEUTICS INC | 300,000 | -1,615,000 | $12,228 |
GPCR | 300,000 | -1,615,000 | $12,228 |
ZURA BIO LTD | 2,523,000 | UNCH | $11,782 |
ZURA | 2,523,000 | UNCH | $11,782 |
NEKTAR THERAPEUTICS | 18,400,000 | UNCH | $10,396 |
NKTR | 18,400,000 | UNCH | $10,396 |
PROTHENA CORP PLC | $9,085 | ||
Call | 500,000 | +500,000 | $18,170 |
Put | 250,000 | UNCH | $9,085 |
See Full List: All Stocks Held By Deep Track Capital LP
— Including:
Biggest new positions
Biggest exits
Biggest increased positions
Biggest decreased positions
See Details: Top 10 Stocks Held By Deep Track Capital LP
Size ($ in 1000's)
At 12/31/2023: $2,975,772 At 09/30/2023: $2,590,825 Deep Track Capital LP holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from Deep Track Capital LP 13F filings. Link to 13F filings: SEC filings |